BMS-754807
CAS: 1001350-96-4
Ref. TM-T2349
| 1mg | 49.00 € | ||
| 2mg | 69.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 163.00 € | ||
| 25mg | 321.00 € | ||
| 50mg | 525.00 € | ||
| 100mg | 755.00 € | ||
| 1ml*10 (DMSO) | 114.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Product Information
Name:
BMS-754807
Synonyms:
- BMS 754807, BMS754807
- (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide
CAS:
Description:
Dual IGF-1R/InsR Inhibitor BMS-754807 is an oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic activity.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
461.49
Formula:
C23H24FN9O
Purity:
98.86%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2349 BMS-754807
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
